Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-32,941
Closed -$188K 2935
2020
Q4
$188K Hold
32,941
﹤0.01% 1612
2020
Q3
$219K Hold
32,941
﹤0.01% 1468
2020
Q2
$292K Buy
+32,941
New +$94.6K ﹤0.01% 1389
2019
Q1
Sell
-18,701
Closed -$35K 2580
2018
Q4
$35K Buy
18,701
+2,642
+16% +$7.86K ﹤0.01% 2067
2018
Q3
$46K Sell
16,059
-7,404
-32% -$22.5K ﹤0.01% 2043
2018
Q2
$71K Buy
23,463
+21,933
+1,434% +$101K ﹤0.01% 1960
2018
Q1
$8K Sell
1,530
-1,279
-46% -$8.26K ﹤0.01% 2272
2017
Q4
$17K Buy
+2,809
New +$19.6K ﹤0.01% 2181
2016
Q2
Sell
-405
Closed -$7K 2351
2016
Q1
$7K Buy
+405
New +$7.22K ﹤0.01% 2226
2014
Q2
Sell
-5,500
Closed -$370K 2392
2014
Q1
$370K Buy
+5,500
New +$340K ﹤0.01% 1536

Other funds holding VXRT

Panagora Asset Management's VXRT Position: Q1 2021 in Review

Panagora Asset Management sold out of Vaxart (VXRT) in Q1 2021, closing a stake of 32,941 shares — an estimated $188K sold.

Panagora Asset Management first reported a position in VXRT in Q1 2014 and held it in 10 quarters. The position peaked at $370K in Q1 2014. 159 funds tracked by Wall St. Rank hold VXRT as of Q1 2021.

  • Panagora Asset Management reported no remaining Vaxart position as of Q1 2021 after selling out during the quarter.
  • Panagora Asset Management sold 32,941 Vaxart shares in Q1 2021, an estimated $188K.
  • Panagora Asset Management first reported a position in Vaxart in Q1 2014 and held it in 10 quarters.
  • Panagora Asset Management's Vaxart position peaked at $370K in Q1 2014.
  • 159 funds tracked by Wall St. Rank held Vaxart as of Q1 2021.

Based on Panagora Asset Management's 13F filing for Q1 2021, filed 12 May 2021.